M
Power Law company profile
Myovant Sciences
Biotech & Life Sciences · Brisbane, United States · Founded 2016 · IPO 2016 Unicorn
Valuation
$2.72B
Market cap · 2026
Revenue
$405M
Latest reported FY
Global footprint
Where Myovant Sciences has talent and traffic
Web traffic by country
180
monthly visits
across markets
across markets
🇺🇸 United States111.1%
Patent intelligence
$77M patent portfolio · 18 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$77M
2.8% of market cap · 26.2× smaller than top peer Ablynx ($2B)
18 active patent families
Where Myovant Sciences innovates
TetrahydrothiophenePyridazinePyrimidinePharmaceutical drugAmino radical
Above peer median on Market
Quality vs same-sector peers
Myovant Sciences on the five Patsnap quality dimensions
Myovant Sciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Myovant Sciences concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Myovant Sciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Myovant Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.